Metabolic Markers

PMV prepares to file first p53 cancer therapy

PMV Pharma prepares to file for approval of rezatopopt, the first oral p53 cancer therapy, in 2027 after successful phase 2 ovarian cancer trial.

By Maya Puspitasari · Sep 2, 2026
Metabolic Markers

Digital Health Pharmacy Practices Indonesia

Digital health is revolutionizing the way healthcare services are delivered globally, including in Indonesia. With advancements in technology, the integration of digital solutions in pharmacy...

By Maumereng · Aug 26, 2026